This website is intended for UK healthcare professionals only Log in | Register

Video

October 2016

European Society of Cardiology Congress 2016 Practice messages 2 – CAD

Dr Jubin Joseph

Content

The potential of imaging to help avoid unnecessary coronary angiography is discussed by Dr Jubin Joseph (St Thomas’ Hospital, London) as well as the continuing debate about the benefits of bare metal versus drug-eluting stents, which was thrown into the spotlight again at the ESC.

| View

October 2016

European Society of Cardiology Congress 2016 Practice messages 3 – telemonitoring and HF

Dr Jubin Joseph

Content

Results of two clinical studies to evaluate the possible benefits of telemonitoring in the management of heart failure are discussed by Dr Jubin Joseph (St Thomas’ Hospital, London).

| View

October 2016

European Society of Cardiology Congress 2016 Practice messages 4 – lipids

Professor Patrick M Moriarty

Content

A reduction in the costly dialysis-like treatment of lipoprotein apheresis looks possible for FH patients following results from a study with the PCSK9 inhibitor alirocumab. Professor Patrick M Moriarty (University of Kansas Medical Center, USA) discusses the implications.

| View

October 2015

European Society of Cardiology Congress 2015 Highlights 1

Dr Terry McCormack, Professor Barbara Casadei

Content

New advances in hypertension, including a breakthrough for the treatment of resistant hypertension is discussed by Dr Terry McCormack, while Professor Barbara Casadei discusses the different presentation and co-morbidities of cardiovascular disease in women.

| View

October 2015

European Society of Cardiology Congress 2015 Highlights 2

Dr Yassir Javaid, Dr Jubin Joseph, Dr Afzal Sohaib

Content

An update of new treatments for heart failure is given by Dr Afzal Sohaib talking to Dr Jubin Joseph. Take home messages for general practitioners in the fields of heart failure and anticoagulation are given by Dr Yassir Javaid.

| View

October 2015

European Society of Cardiology Congress 2015 Highlights 3

Dr Peter Lansberg, Dr Afzal Sohaib, Dr Jubin Joseph

Content

The latest news from lipid-lowering studies with monoclonal antibodies – the PCSK9 inhibitors – is discussed by Dr Peter Lansberg. An update on new devices including a leadless pacemaker and a bioresabsorbable scaffold is reported by Drs Afzal Sohaib and Jubin Joseph, who also talk about advances in the treatment of acute myocardial infarction.

| View
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now